The apelinergic system: a promising therapeutic target

Bibliography

• O'Dowd BF, Heiber M, Chan A, A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993;136(1-2):355-60
   PubMedGoogle Scholar
• Tatemoto K, Hosoya M, Habata Y, Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998;251(2):471-6
   PubMed Web of Science ®Google Scholar
• Hosoya M, Kawamata Y, Fukusumi S, Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000;275(28):21061-7
   PubMedGoogle Scholar
• Kawamata Y, Habata Y, Fukusumi S, Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001;1538(2-3):162-71
   PubMed Web of Science ®Google Scholar
• Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol 2008;90(5):343-9
   PubMedGoogle Scholar
• Lee DK, George SR, O'Dowd BF. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci 2006;27(4):190-4
   PubMedGoogle Scholar
• Sorli SC, van den Berghe L, Masri B, Therapeutic potential of interfering with apelin signalling. Drug Discov Today 2006;11(23-24):1100-6
   PubMedGoogle Scholar
• Susaki E, Wang G, Cao G, Apelin cells in the rat stomach. Regul Pept 2005;129(1-3):37-41
   PubMedGoogle Scholar
• Lee DK, Cheng R, Nguyen T, Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74(1):34-41
   PubMed Web of Science ®Google Scholar
• O'Carroll AM, Selby TL, Palkovits M, Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 2000;1492(1):72-80
   PubMedGoogle Scholar
• De Mota N, Lenkei Z, Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 2000;72(6):400-7
   PubMedGoogle Scholar
• Edinger AL, Hoffman TL, Sharron M, An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 1998;72(10):7934-40
   PubMedGoogle Scholar
• Choe H, Farzan M, Konkel M, The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol 1998;72(7):6113-8
   PubMedGoogle Scholar
• Cox CM, D'Agostino SL, Miller MK, Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006;296(1):177-89
   PubMedGoogle Scholar
• Sorli SC, Le Gonidec S, Knibiehler B, Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007;26(55):7692-9
   PubMedGoogle Scholar
• Glassford AJ, Yue P, Sheikh AY, HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab 2007;293(6):E1590-6
   PubMedGoogle Scholar
• Sheikh AY, Chun HJ, Glassford AJ, In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 2008;294(1):H88-98
   PubMedGoogle Scholar
• Masri B, Knibiehler B, Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 2005;17(4):415-26
   PubMedGoogle Scholar
• O'Carroll AM, Don AL, Lolait SJ. APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. J Neuroendocrinol 2003;15(11):1095-101
   PubMedGoogle Scholar
• Clarke KJ, Whitaker KW, Reyes TM. Diminished metabolic responses to centrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet. J Neuroendocrinol 2009;21(2):83-9
   PubMedGoogle Scholar
• Habata Y, Fujii R, Hosoya M, Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999;1452(1):25-35
   PubMedGoogle Scholar
• Masri B, Lahlou H, Mazarguil H, Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 2002;290(1):539-45
   PubMedGoogle Scholar
• Masri B, Morin N, Cornu M, Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 2004;18(15):1909-11
   PubMedGoogle Scholar
• Tatemoto K, Takayama K, Zou MX, The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001;99(2-3):87-92
   PubMedGoogle Scholar
• Szokodi I, Tavi P, Foldes G, Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002;91(5):434-40
   PubMed Web of Science ®Google Scholar
• Medhurst AD, Jennings CA, Robbins MJ, Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003;84(5):1162-72
   PubMedGoogle Scholar
• Maguire JJ, Kleinz MJ, Pitkin SL, [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension 2009;54(3):598-604
   PubMed Web of Science ®Google Scholar
• Azizi M, Iturrioz X, Blanchard A, Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol 2008;19(5):1015-24
   PubMedGoogle Scholar
• Tatemoto K. Search for an endogenous ligand of the orphan G protein-coupled receptor–discovery of apelin, a novel biologically active peptide. Nippon Rinsho 2000;58(3):737-46
   PubMedGoogle Scholar
• Zhou N, Zhang X, Fan X, The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity. Virology 2003;317(1):84-94
   PubMedGoogle Scholar
• Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005;107(2):198-211
   PubMedGoogle Scholar
• De Mota N, Reaux-Le Goazigo A, El Messari S, Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 2004;101(28):10464-9
   PubMedGoogle Scholar
• Boucher J, Masri B, Daviaud D, Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005;146(4):1764-71
   PubMed Web of Science ®Google Scholar
• Chen MM, Ashley EA, Deng DX, Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003;108(12):1432-9
   PubMed Web of Science ®Google Scholar
• Chong KS, Gardner RS, Morton JJ, Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail 2006;8(4):355-60
   PubMed Web of Science ®Google Scholar
• Foldes G, Horkay F, Szokodi I, Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003;308(3):480-5
   PubMed Web of Science ®Google Scholar
• Heinonen MV, Purhonen AK, Miettinen P, Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept 2005;130(1-2):7-13
   PubMedGoogle Scholar
• Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 2005;126(3):233-40
   PubMedGoogle Scholar
• Carpene C, Dray C, Attane C, Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 2007;63(4):359-73
   PubMedGoogle Scholar
• Daviaud D, Boucher J, Gesta S, TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 2006;20(9):1528-30
   PubMed Web of Science ®Google Scholar
• Reaux A, De Mota N, Skultetyova I, Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001;77(4):1085-96
   PubMedGoogle Scholar
• Ashley EA, Powers J, Chen M, The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005;65(1):73-82
   PubMed Web of Science ®Google Scholar
• Ellinor PT, Low AF, Macrae CA. Reduced apelin levels in lone atrial fibrillation. Eur Heart J 2006;27(2):222-6
   PubMedGoogle Scholar
• Ronkainen VP, Ronkainen JJ, Hanninen SL, Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007;21(8):1821-30
   PubMedGoogle Scholar
• Jia YX, Pan CS, Zhang J, Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept 2006;133(1-3):147-54
   PubMedGoogle Scholar
• Berry MF, Pirolli TJ, Jayasankar V, Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004;110(11 Suppl 1):II187-93
   PubMed Web of Science ®Google Scholar
• Goetze JP, Rehfeld JF, Carlsen J, Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept 2006;133(1-3):134-8
   PubMedGoogle Scholar
• Falcao-Pires I, Goncalves N, Henriques-Coelho T, Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009;296(6):H2007-14
   PubMed Web of Science ®Google Scholar
• Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 2006;553(1-3):222-8
   PubMed Web of Science ®Google Scholar
• Brunner F, Bras-Silva C, Cerdeira AS, Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006;111(2):508-31
   PubMed Web of Science ®Google Scholar
• Batenburg WW, Garrelds IM, Bernasconi CC, Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 2004;109(19):2296-301
   PubMedGoogle Scholar
• Cheng X, Cheng XS, Pang CC. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol 2003;470(3):171-5
   PubMed Web of Science ®Google Scholar
• Katugampola SD, Maguire JJ, Matthewson SR, [125I]-(Pyr1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 2001;132(6):1255-60
   PubMed Web of Science ®Google Scholar
• Salcedo A, Garijo J, Monge L, Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids. Regul Pept 2007;144(1-3):50-5
   PubMedGoogle Scholar
• Zhang J, Ren CX, Qi YF, Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. Life Sci 2006;79(12):1153-9
   PubMedGoogle Scholar
• Inui M, Fukui A, Ito Y, Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol 2006;298(1):188-200
   PubMedGoogle Scholar
• Zeng XX, Wilm TP, Sepich DS, Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev Cell 2007;12(3):391-402
   PubMedGoogle Scholar
• Scott IC, Masri B, D'Amico LA, The G protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell 2007;12(3):403-13
   PubMedGoogle Scholar
• D'Aniello C, Lonardo E, Iaconis S, G protein-coupled receptor APJ and its ligand apelin act downstream of cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway. Circ Res 2009;105(3):231-8
   PubMedGoogle Scholar
• Ishida J, Hashimoto T, Hashimoto Y, Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004;279(25):26274-9
   PubMedGoogle Scholar
• Kuba K, Zhang L, Imai Y, Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res 2007;101(4):e32-42
   PubMed Web of Science ®Google Scholar
• Vickers C, Hales P, Kaushik V, Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002;277(17):14838-43
   PubMedGoogle Scholar
• Danilczyk U, Penninger JM. Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 2006;98(4):463-71
   PubMedGoogle Scholar
• Iusuf D, Henning RH, van Gilst WH, Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives. Eur J Pharmacol 2008;585(2-3):303-12
   PubMedGoogle Scholar
• Devic E, Rizzoti K, Bodin S, Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 1999;84(1-2):199-203
   PubMedGoogle Scholar
• Saint-Geniez M, Argence CB, Knibiehler B, The msr/apj gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. Gene Expr Patterns 2003;3(4):467-72
   PubMedGoogle Scholar
• Kasai A, Shintani N, Oda M, Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004;325(2):395-400
   PubMedGoogle Scholar
• Kidoya H, Ueno M, Yamada Y, Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 2008;27(3):522-34
   PubMedGoogle Scholar
• Kalin RE, Kretz MP, Meyer AM, Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol 2007;305(2):599-614
   PubMedGoogle Scholar
• Hashimoto T, Kihara M, Imai N, Requirement of apelin–apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol 2007;171(5):1705-12
   PubMedGoogle Scholar
• Malyszko J, Malyszko JS, Kozminski P, Apelin and cardiac function in hemodialyzed patients: possible relations? Am J Nephrol 2006;26(2):121-6
   PubMedGoogle Scholar
• Malyszko J, Malyszko JS, Pawlak K, Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Transplant Proc 2008;40(10):3466-9
   PubMedGoogle Scholar
• Zhong JC, Huang Y, Yung LM, The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Regul Pept 2007;144(1-3):109-14
   PubMedGoogle Scholar
• Hus-Citharel A, Bouby N, Frugiere A, Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 2008;74(4):486-94
   PubMedGoogle Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89(6):2548-56
   PubMed Web of Science ®Google Scholar
• Sorhede Winzell M, Magnusson C, Ahren B. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 2005;131(1-3):12-7
   PubMedGoogle Scholar
• Higuchi K, Masaki T, Gotoh K, Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 2007;148(6):2690-7
   PubMedGoogle Scholar
• Zhong JC, Yu XY, Huang Y, Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 2007;74(3):388-95
   PubMedGoogle Scholar
• Li L, Yang G, Li Q, Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006;114(10):544-8
   PubMedGoogle Scholar
• Reaux A, Gallatz K, Palkovits M, Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 2002;113(3):653-62
   PubMedGoogle Scholar
• Brailoiu GC, Dun SL, Yang J, Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett 2002;327(3):193-7
   PubMedGoogle Scholar
• Wang G, Anini Y, Wei W, Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 2004;145(3):1342-8
   PubMedGoogle Scholar
• Taheri S, Murphy K, Cohen M, The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 2002;291(5):1208-12
   PubMedGoogle Scholar
• Sunter D, Hewson AK, Dickson SL. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003;353(1):1-4
   PubMedGoogle Scholar
• O'Shea M, Hansen MJ, Tatemoto K, Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 2003;6(3):163-7
   PubMedGoogle Scholar
• Han S, Wang G, Qiu S, Increased colonic apelin production in rodents with experimental colitis and in humans with IBD. Regul Pept 2007;142(3):131-7
   PubMedGoogle Scholar
• Principe A, Melgar-Lesmes P, Fernandez-Varo G, The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 2008;48(4):1193-201
   PubMedGoogle Scholar
• Roberts E, Newson M, Pope G, Abnormal fluid homeostasis in apelin receptor knockout mice. J Endocrinol 2009;202(3):453-62
   PubMedGoogle Scholar
• Newson MJ, Roberts EM, Pope GR, The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms. J Endocrinol 2009;202(1):123-9
   PubMedGoogle Scholar
• Choe W, Albright A, Sulcove J, Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. J Neurovirol 2000;6(Suppl 1):S61-9
   PubMedGoogle Scholar
• Zou MX, Liu HY, Haraguchi Y, Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Lett 2000;473(1):15-8
   PubMedGoogle Scholar
• Cayabyab M, Hinuma S, Farzan M, Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. J Virol 2000;74(24):11972-6
   PubMedGoogle Scholar
• Brophy JM, Joseph L, Rouleau JL. beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001;134(7):550-60
   PubMedGoogle Scholar
• McMurray JJ, Ostergren J, Swedberg K, Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362(9386):767-71
   PubMedGoogle Scholar
• Leite-Moreira AF. Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 2006;92(5):712-8
   PubMedGoogle Scholar
• Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. Acute neurohumoral modulation of diastolic function. Peptides 2009;30(2):419-25
   PubMedGoogle Scholar
• Lee DK, Lanca AJ, Cheng R, Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 2004;279(9):7901-8
   PubMed Web of Science ®Google Scholar
• Boivin B, Allen BG. Regulation of membrane-bound PKC in adult cardiac ventricular myocytes. Cell Signal 2003;15(2):217-24
   PubMedGoogle Scholar